Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenomic Reprogramming as a Driver of Malignant Glioma
Richard E. Phillips, Alexey A. Soshnev, C. David Allis
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 647-660
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 293
EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3
Ziwen Pan, Rongrong Zhao, Boyan Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 209
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Yanlin Wu, Zhengjun Lin, Changchun Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 188
LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond
Wanxu Huang, Hua Li, Qingsong Yu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 143
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 62
Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
Zhong Lan, Xin Li, Xiao-Qin Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3040-3040
Open Access | Times Cited: 33
Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
Ni Tong, Zhenqiang He, Yujie Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 62
Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
Aiqun Liu, Baohong Jiang, Cailu Song, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 40
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 39
From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
Brittany Dewdney, Misty R. Jenkins, Sarah A. Best, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 38
Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors
Giulia Giacomini, Sandra Piquet, Odile Chevallier, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 5, pp. 2372-2388
Open Access | Times Cited: 13
Mechanistic insight into glioma through spatially multidimensional proteomics
Lei Shen, Zhourui Zhang, Pengfei Wu, et al.
Science Advances (2024) Vol. 10, Iss. 7
Open Access | Times Cited: 9
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
Ryan T. Wagner, Ryan A. Hlady, Xiaoyu Pan, et al.
Genome biology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells
Jixing Zhao, Weili Jin, Kaikai Yi, et al.
Pharmacological Research (2021) Vol. 171, pp. 105764-105764
Closed Access | Times Cited: 43
H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape
Noa Furth, Danielle Algranati, Bareket Dassa, et al.
Cell Reports (2022) Vol. 39, Iss. 7, pp. 110836-110836
Open Access | Times Cited: 35
Macrophage’s role in solid tumors: two edges of a sword
Arian Jahandideh, Mahsa Yarizadeh, Maryam Noei-Khesht Masjedi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma
Qian Zhang, Lucia Yang, Ying Hsiu Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 691
Open Access | Times Cited: 18
Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways
Marianna Zolotovskaia, Alexander Modestov, Maria Suntsova, et al.
DNA repair (2023) Vol. 123, pp. 103448-103448
Closed Access | Times Cited: 17
PRMT1 driven PTX3 regulates ferritinophagy in glioma
Kirti Lathoria, Pruthvi Gowda, Sonia B. Umdor, et al.
Autophagy (2023) Vol. 19, Iss. 7, pp. 1997-2014
Open Access | Times Cited: 17
Crosstalk within and beyond the Polycomb repressive system
Tianyi Shi, Hiroki Sugishita, Yukiko Gotoh
The Journal of Cell Biology (2024) Vol. 223, Iss. 5
Open Access | Times Cited: 6
Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
Eric Huang
Biomedicines (2022) Vol. 10, Iss. 2, pp. 246-246
Open Access | Times Cited: 26
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Swati Dhar, Samantha Gadd, Priyam Patel, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Targeting epigenetic regulation for cancer therapy using small molecule inhibitors
Amit Kumar, Luni Emdad, Paul B. Fisher, et al.
Advances in cancer research (2023), pp. 73-161
Closed Access | Times Cited: 15
Exosomal circRNAs as promising liquid biopsy biomarkers for glioma
Xiaoke Wu, Mengmeng Shi, Yajun Lian, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top